Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

4 Results Found

Letter/Comment
Public

AHA Response to OMB Deregulation RFI

AHA responds to the Office of Management and Budget Deregulation Request for Information.
Letter/Comment
Public

AHA Comments on FTC Anticompetitive Deregulations RFI

The AHA provides an overview of the key statutes and regulations that have impeded competition in the health care market and offer a series of recommendations to remedy these obstacles.
Letter/Comment
Public

AHA Comments on DOJ Anticompetitive Deregulations RFI

The AHA provides an overview of the key statutes and regulations that have impeded competition in the health care market and offer a series of recommendations to remedy these obstacles.
Letter/Comment
Member

AHA Letter to UnitedHealthcare RE: Molecular Pathology Reimbursement Policy

AHA addresses UnitedHealthcare’s implementation of its Molecular Pathology Reimbursement Policy on April 1, 2024.